As I am sure is the case for many of you, if I had known 4 years ago what I know now I may have done things a little differently.  Like many of you, I paid too much but then probably not as much as some.  Like many of you, I am also rather disallusioned.  That tends to happen when your investment is trading at a valuation less than what you paid for it.  Like many of you, I am also skeptical of DM's projections as to when things will happen because he is always way ahead of himself, and too often way ahead.  For that reason I am 'skeptical' that BOM2 will start this year.  If it does, great, but I'm not holding my breath.

I'm also holding about the same number of the 'a' warrants as I am stock so I'm getting a bit edgy about whether those will be worth anything meaningful by June 2023.  The only hope for that possibility is a successful Covid trial and/or a buyout, although I doubt there will be a buyout without a successful Covid trial.  Covid is still out there even though, for now, and despite the press coverage of a month or two ago, its mostly off people's radar due to the significant easing of Covid restrictions and the very troublesome situation in Ukraine.  Nevertheless, it seems more likely than not we will have some meaningful results from the Covid trial at some point in the coming months or at the very least the coming year.  A positive result will be helpful but how helpful is hard to predict.  

One thing worth mentioning, I think, is that based on the previous presentation it stated that about 30% of the common shares (243M) are held by retail investors.  I also suspect this may be a bit less because of shares owned by company employees, their families, etc. that are not being actively traded.  Even so, we're still taling about 73 million shares, which is a lot of shares that don't seem to be trading.......at all.  So, the actual trading volume that establishes the stock price would seem to be based on the relatively low numbers we have all seen, and for sure it's nowhere near 73M.  From this I conclude that RVX is far more of a private company than the other 70% ownership might suggest.

Having to look at a .40-.55 cent share price every day sucks.  No way to sugar coat it but given this outfit is so tightly held it also may not tell the whole story.  I'm at least hopeful that all of the publications, initiatives, collaborations and trials will, at some point, yield positive results.  At least the darn (trying to be clean here) company is still operating and I have no reason to doubt that it will continue to do so through to the conclusion of the BOM2 trial.

Keeping the faith in challenging times.  Nothing else to do......IMO.

P